What does REGATTA PHARMA do?

REGATTA PHARMA is a logistics company in Stekene. Private Limited, started on 27 December 1983, 1 establishment.

What is the address of REGATTA PHARMA?

The registered office of REGATTA PHARMA is located at Dorpsstraat(STE) 29, 9190 Stekene.

Is REGATTA PHARMA still active?

Yes. According to the CBE (29 October 2026) REGATTA PHARMA is active, legal situation “Normale toestand”, started on 27 December 1983.

Is REGATTA PHARMA registered on Peppol?

Yes, REGATTA PHARMA is registered on the Peppol network with ID 0208:0425115069.

What is the enterprise number of REGATTA PHARMA?

The enterprise number of REGATTA PHARMA is BE0425115069.

When was REGATTA PHARMA founded?

REGATTA PHARMA was founded on 27 December 1983.

Who are the directors of REGATTA PHARMA?

According to the 2025 annual accounts, the directors of REGATTA PHARMA are: PATRIMANNE BV.

Is REGATTA PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 December 1983; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did REGATTA PHARMA make in 2025?

REGATTA PHARMA posted a profit after taxes of € 15,827 in financial year 2025.

What is the revenue of REGATTA PHARMA?

As a small company, REGATTA PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 118,489.

How much does an employee at REGATTA PHARMA earn?

The average wage cost per full-time employee at REGATTA PHARMA was € 65,700 in 2025: staff costs of € 72,316 for 1.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does REGATTA PHARMA have?

According to the 2025 annual accounts, REGATTA PHARMA has 1.1 full-time equivalents (FTE).

REGATTA PHARMA (Private Limited) - Stekene - BE0425115069

Dossier REGATTA PHARMA, printed on 29 October 2026 from databakkes.be/en/0425115069/regatta-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 21 % of short-term debt in 2025; threshold 65 %.
Figures corrected NBB

Corrected annual account filed for 2025.

Financials

Financial year 2025

REGATTA PHARMA from Stekene, company number BE0425115069, closed financial year 2025 with a result of € 15,827 after tax. For that financial year REGATTA PHARMA recorded a gross margin of € 118,489 and equity of € -199,594. Compared with financial year 2024, the result moved from € 10,159 to € 15,827. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2026.

What it is worth Caution

€ -199,594

▲ € 15,827 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 15,827

▲ 56% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 18,925

▲ € 16,433 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -219,594.

People and assets in 2025

Full-time equivalents

1.1

▼ 0.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 72,316

▼ 42% vs 2024

€ 65,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,146

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 379,474

▼ 9% vs 2024

€ 40,328 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 2,886

▼ 92% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 9,100

▼ 69% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 115,989 Gross margin 2022: € 115,989 First fiscal year in the series	€ 69,192 Gross margin 2023: € 69,192 ▼ 40% vs 2022 (€ 115,989) Unfavourable step	€ 173,488 Gross margin 2024: € 173,488 ▲ 151% vs 2023 (€ 69,192) Favourable step	€ 118,489 Gross margin 2025: € 118,489 ▼ 32% vs 2024 (€ 173,488) Unfavourable step	▼ 32%
Profit after taxes	€ -65,416 Profit after taxes 2022: € -65,416 First fiscal year in the series	€ -40,352 Profit after taxes 2023: € -40,352 ▲ € 25,065 vs 2022 (€ -65,416) Favourable step	€ 10,159 Profit after taxes 2024: € 10,159 ▲ € 50,511 vs 2023 (€ -40,352) Favourable step	€ 15,827 Profit after taxes 2025: € 15,827 ▲ 56% vs 2024 (€ 10,159) Favourable step	▲ 56%
Equity	€ -185,228 Equity 2022: € -185,228 First fiscal year in the series	€ -225,580 Equity 2023: € -225,580 ▼ € 40,352 vs 2022 (€ -185,228) Unfavourable step	€ -215,421 Equity 2024: € -215,421 ▲ € 10,159 vs 2023 (€ -225,580) Favourable step	€ -199,594 Equity 2025: € -199,594 ▲ € 15,827 vs 2024 (€ -215,421) Favourable step	▲ € 15,827
Total debts	€ 845,500 Total debts 2022: € 845,500 First fiscal year in the series	€ 1,081,916 Total debts 2023: € 1,081,916 ▲ 28% vs 2022 (€ 845,500) Unfavourable step	€ 1,031,439 Total debts 2024: € 1,031,439 ▼ 5% vs 2023 (€ 1,081,916) Favourable step	€ 792,896 Total debts 2025: € 792,896 ▼ 23% vs 2024 (€ 1,031,439) Favourable step	▼ 23%
Cash	€ 11,551 Cash 2022: € 11,551 First fiscal year in the series	€ 15,215 Cash 2023: € 15,215 ▲ 32% vs 2022 (€ 11,551) Favourable step	€ 2,492 Cash 2024: € 2,492 ▼ 84% vs 2023 (€ 15,215) Unfavourable step	€ 18,925 Cash 2025: € 18,925 ▲ € 16,433 vs 2024 (€ 2,492) Favourable step	▲ € 16,433
Land & buildings	€ 471,519 Land & buildings 2022: € 471,519 First fiscal year in the series	€ 448,569 Land & buildings 2023: € 448,569 ▼ 5% vs 2022 (€ 471,519) Unchanged	€ 425,619 Land & buildings 2024: € 425,619 ▼ 5% vs 2023 (€ 448,569) Unchanged	€ 402,669 Land & buildings 2025: € 402,669 ▼ 5% vs 2024 (€ 425,619) Unchanged	▼ 5%
Retained profit	€ -205,228 Retained profit 2022: € -205,228 First fiscal year in the series	€ -245,580 Retained profit 2023: € -245,580 ▼ € 40,352 vs 2022 (€ -205,228) Unfavourable step	€ -235,421 Retained profit 2024: € -235,421 ▲ € 10,159 vs 2023 (€ -245,580) Favourable step	€ -219,594 Retained profit 2025: € -219,594 ▲ € 15,827 vs 2024 (€ -235,421) Favourable step	▲ € 15,827
Bank debt	€ 446,865 Bank debt 2022: € 446,865 First fiscal year in the series	€ 416,578 Bank debt 2023: € 416,578 ▼ 7% vs 2022 (€ 446,865) Favourable step	€ 419,178 Bank debt 2024: € 419,178 ▲ 1% vs 2023 (€ 416,578) Unfavourable step	€ 379,474 Bank debt 2025: € 379,474 ▼ 9% vs 2024 (€ 419,178) Favourable step	▼ 9%
Balance sheet total	€ 660,272 Balance sheet total 2022: € 660,272 First fiscal year in the series	€ 856,335 Balance sheet total 2023: € 856,335 ▲ 30% vs 2022 (€ 660,272) Unchanged	€ 816,018 Balance sheet total 2024: € 816,018 ▼ 5% vs 2023 (€ 856,335) Unchanged	€ 593,302 Balance sheet total 2025: € 593,302 ▼ 27% vs 2024 (€ 816,018) Unchanged	▼ 27%
Employees (FTE)	-	-	1.8 Employees (FTE) 2024: 1.8 First fiscal year in the series	1.1 Employees (FTE) 2025: 1.1 ▼ 0.7 vs 2024 (1.8) Unchanged	▼ 0.7

Key figures of REGATTA PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to REGATTA PHARMA?

What happened at REGATTA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 23, 2026 Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
2021 PATRIMANNE BV became a director. NBB
Jan 3, 1984 New establishment in Antwerpen. KBO
Dec 27, 1983 Start of the company according to the CBE. KBO

In short

From € 65,417 loss in 2022 to € 15,827 profit in 2025.

Best year ever: 2025, with € 15,827 profit.

On average € 107,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PATRIMANNE BV

REGATTA PHARMA

Behind REGATTA PHARMA is PATRIMANNE BV.

Directors

According to the 2025 annual accounts

PATRIMANNE BV

Director · represented by HOFMAN Anne

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat(STE) 29

9190 Stekene

2.023.704.466

Blancefloerlaan 309

2050 Antwerpen

Active since 3 January 1984

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

Dentimo

€ 8,355 gross margin · 2025

Patrimanne same network

€ 83,814 gross margin · 2024

BTWE GLOBAL PHARMA

BacH

€ 8,448 gross margin · 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0425.115.069

VAT number

BE 0425.115.069

Registered office

Dorpsstraat(STE) 29, 9190 Stekene

Names & denominations

REGATTA PHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 December 1983

Peppol

Active · Active since 15 Dec 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Detailhandel in drogisterijartikelen en onderhoudsproducten

Gespecialiseerde detailhandel in drogisterijartikelen en onderhoudsproducten

Detailhandel in drogisterijartikelen en onderhoudsproducten in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

REGATTA PHARMA

Warning lights

Financials

What happened to REGATTA PHARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions